The Regulation (EU) 2021/2282 on health technology assessment (HTAR) entered into force on 11 January 2022 and will apply from 12 January 2025.
In the preparatory phase for the implementation of the HTAR (January 2022 – January 2025), this webpage aims at informing national authorities, health technology developers and stakeholders about the development of implementing legislation in accordance with the powers conferred to the Commission by the co-legislators.
In the implementation phase of the HTAR (beyond January 2025, when joint HTA work will start), this webpage will include all the information required by Article 30.3 of the HTAR.
- Joint Clinical Assessments
- Joint Scientific Consultations
- Factsheet on implementation of the Regulation
- Joint clinical assessment of medicinal products: Submission of early information by health technology developers
Implementation rolling plan
The rolling plan below contains a list of key activities that the European Commission has carried out or intends to carry out in preparation for the implementation of Regulation (EU) 2021/2282.
The plan is subject to regular review in order to provide national authorities, health technology developers and stakeholders with the most updated information.